Skip to main content
SpringerLink
Log in

Endolumenal GERD Therapies

  • Chapter
  • First Online:
The SAGES Manual Operating Through the Endoscope

  • 865 Accesses

Abstract

Gastroesophageal reflux disease is one of the most common digestive illnesses. Although the mainstay of therapy is medication, this does little to address the underlying problem of an ineffective barrier to reflux of gastric contents into the esophagus. Lifestyle changes of weight loss and positional changes when supine, while shown to be effective in reflux disease, are difficult to achieve on a widespread basis. Procedures to create a more effective antireflux barrier, whether laparoscopic or endolumenal, have met with limited acceptance due to concerns about efficacy and side effects. This chapter reviews the current status of three currently available endoluminal therapies to treat gastroesophageal reflux disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhao Y. Gastroesophageal reflux disease (GERD) hospitalizations in 1998 and 2005 – HCUP-US home page. In: HCUP, editor. Online 2012.

    Google Scholar 

  2. Goff VV. Managing esophageal reflux disease. National Business Group on health guide for employers using comparative effectiveness research. 2011. https://www.businessgrouphealth.org/pub/f3124c77-2354-d714-5109-a5dddf683531

  3. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825–31. PubMed eng.

    Article  CAS  PubMed  Google Scholar 

  4. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006;166(9):965–71. PubMed.

    Article  PubMed  Google Scholar 

  5. Bytzer P, van Zanten SV, Mattsson H, Wernersson B. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis – a post hoc analysis of 5796 patients. Aliment Pharmacol Ther. 2012;36(7):635–43. PubMed.

    Article  CAS  PubMed  Google Scholar 

  6. Agency MaHpR. Domperidone: risks of cardiac side effects—indication restricted to nausea A1 and vomiting, new contraindications, and reduced dose and duration of use. Drug Safety Update. 2014;7(10).

    Google Scholar 

  7. Ehrenpreis ED, Deepak P, Sifuentes H, Devi R, Du H, Leikin JB. The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits. Am J Gastroenterol. 2013;108(6):866–72. PubMed.

    Article  CAS  PubMed  Google Scholar 

  8. Lundell L, Attwood S, Ell C, Fiocca R, Galmiche JP, Hatlebakk J, et al. Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut. 2008;57(9):1207–13. PubMed eng.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28. quiz 29. PubMed.

    Article  PubMed  Google Scholar 

  10. Kahrilas PJ. GERD pathogenesis, pathophysiology, and clinical manifestations. Cleve Clin J Med. 2003;70 Suppl 5:S4–19. PubMed.

    Article  PubMed  Google Scholar 

  11. Richardson WS, Trus TL, Thompson S, Hunter JG. Nissen and Toupet fundoplications effectively inhibit gastroesophageal reflux irrespective of natural anatomy and function. Surg Endosc. 1997;11(3):261–3. PubMed.

    Article  CAS  PubMed  Google Scholar 

  12. Rinsma NF, Smeets FG, Bruls DW, Kessing BF, Bouvy ND, Masclee AA, et al. Effect of transoral incisionless fundoplication on reflux mechanisms. Surg Endosc. 2014;28(3):941–9. PubMed.

    Article  PubMed  Google Scholar 

  13. Cadiere GB, Buset M, Muls V, Rajan A, Rosch T, Eckardt AJ, et al. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg. 2008;32(8):1676–88. PubMed eng.

    Article  PubMed Central  PubMed  Google Scholar 

  14. DiBaise JK, Brand RE, Quigley EM. Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action. Am J Gastroenterol. 2002;97(4):833–42. PubMed.

    Article  PubMed  Google Scholar 

  15. Kahrilas PJ. The role of hiatus hernia in GERD. Yale J Biol Med. 1999;72(2–3):101–11. PubMed Pubmed Central PMCID: 2579017.

    PubMed Central  CAS  PubMed  Google Scholar 

  16. Triadafilopoulos G, Utley DS. Temperature-controlled radiofrequency energy delivery for gastroesophageal reflux disease: the Stretta procedure. J Laparoendosc Adv Surg Tech A. 2001;11(6):333–9. PubMed.

    Article  CAS  PubMed  Google Scholar 

  17. Arts J, Bisschops R, Blondeau K, Farre R, Vos R, Holvoet L, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012;107(2):222–30. PubMed.

    Article  CAS  PubMed  Google Scholar 

  18. Herman RBM, Murawski M, Nowakowski M, Rys J, Schwarz T, Wojtysiak D, et al. Non-ablative radiofrequency (RF) application to smooth muscle of internal anal sphincter (IAS): a tissue study. Surg Endosc. 2014;28:2323.

    Article  Google Scholar 

  19. Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2012;22(4):283–8. PubMed.

    Article  PubMed  Google Scholar 

  20. Aziz AM, El-Khayat HR, Sadek A, Mattar SG, McNulty G, Kongkam P, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24(4):818–25. PubMed.

    Article  PubMed  Google Scholar 

  21. Franciosa M, Triadafilopoulos G, Mashimo H. Stretta radiofrequency treatment for GERD: a safe and effective modality. Gastroenterol Res Pract. 2013;2013:783815. PubMed Pubmed Central PMCID: 3775401.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Corley DA, Katz P, Wo JM, Stefan A, Patti M, Rothstein R, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003;125(3):668–76. PubMed.

    Article  PubMed  Google Scholar 

  23. Dughera L, Rotondano G, De Cento M, Cassolino P, Cisarò F, et al. Durability of Stretta radiofrequency treatment for GERD: results of an 8-year follow-up. Gastroenterol Res Pract. 2014;2014:5.

    Article  Google Scholar 

  24. Noar M, Squires P, Noar E, Lee M. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28(8):2323–33. PubMed.

    Article  PubMed  Google Scholar 

  25. Jobe BA, O’Rourke RW, McMahon BP, Gravesen F, Lorenzo C, Hunter JG, et al. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg. 2008;248(1):69–76. PubMed eng.

    Article  PubMed  Google Scholar 

  26. Bell RC, Cadiere GB. Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc. 2011;25(7):2387–99. PubMed Pubmed Central PMCID: 3116120.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Bell RC, Mavrelis PG, Barnes WE, Dargis D, Carter BJ, Hoddinott KM, et al. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication. J Am Coll Surg. 2012;215(6):794–809. PubMed.

    Article  PubMed  Google Scholar 

  28. Trad KS, Simoni G, Barnes WE, Shughoury AB, Raza M, Heise JA, et al. Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study. BMC Gastroenterol. 2014;14:174. PubMed.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Trad KS, Turgeon DG, Deljkich E. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms. Surg Endosc. 2012;26(3):650–60. PubMed Pubmed Central PMCID: 3271216.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Wendling MR, Melvin WS, Perry KA. Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature. Surg Endosc. 2013;27(10):3754–61. PubMed.

    Article  PubMed  Google Scholar 

  31. Trad KS, Barnes WE, Simoni G, Shughoury AB, Mavrelis PG, Raza M, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial. Surg Innov. 2014;21. PubMed.

    Google Scholar 

  32. Hunter JG, Kahrilas PJ, Bell RCW, Wilson EB, Trad KS, Dolan JP, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. https://www.businessgrouphealth.org/pub/f3124c77-2354-d714-5109-a5dddf683531

  33. Bell RC, Freeman KD. Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease. Surg Endosc. 2011;25(6):1975–84. PubMed Pubmed Central PMCID: 3098375.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Bell RC et al. Transoral incisionless fundoplication: 2 year results from the prospective multicenter U.S. study. Am Surg. 2014;80(11):1093–105.

    PubMed  Google Scholar 

  35. Furnee EJ, Broeders JA, Draaisma WA, Schwartz MP, Hazebroek EJ, Smout AJ, et al. Laparoscopic Nissen fundoplication after failed EsophyX fundoplication. Br J Surg. 2010;97(7):1051–5. PubMed.

    Article  CAS  PubMed  Google Scholar 

  36. Witteman BP, Kessing BF, Snijders G, Koek GH, Conchillo JM, Bouvy ND. Revisional laparoscopic antireflux surgery after unsuccessful endoscopic fundoplication. Surg Endosc. 2013;27(6):2231–6. PubMed.

    Article  PubMed  Google Scholar 

  37. Perry KA, Linn JG, Eakin JL, Onders RP, Velanovich V, Melvin WS. Transoral incisionless fundoplication does not significantly increase morbidity of subsequent laparoscopic Nissen fundoplication. J Laparoendosc Adv Surg Tech A. 2013;23(5):456–8. PubMed.

    Article  PubMed  Google Scholar 

  38. Bell RCW, Hufford RJ, Fearon J, Freeman KD. Revision of failed traditional fundoplication using EsophyX transoral fundoplication. Surg Endosc. 2013;27:761–7.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Roy-Shapira A, Bapaye A, Kiesslich R, Horgan S, Schoppmann SF, Zacherl J, et al. Mo1488 effective endoscopic treatment of gastroesophageal reflux disease using a new endoscopic stapling system results of a prospective controlled multicenter tria. Gastroenterology. 142(5):S–1076. https://secure.jbs.elsevierhealth.com/action/showCitFormats?pii=S0016-5085%2812%2964180-8&doi=10.1016%2FS0016-5085%2812%2964180-8&code=ygast-site.

  40. Zacherl J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2014;19. PubMed.

    Google Scholar 

  41. Kessler WRM, Gail, Selzer DJ, Lehman GA. Longer term follow up after endoscopic treatment of GERD with the medigus SRS™ endoscopic stapling device. Abstract, DDW 2014.

    Google Scholar 

  42. Bapaye D, Pujari R, Dorwat S, Roy-Shapira A. A pilot study of an endoscopic surgical stapler for the treatment of GERD – five year follow up results. Abstract, UEG week 2013.

    Google Scholar 

  43. Markus PM, Horstmann O, Kley C, Neufang T, Becker H. Laparoscopic fundoplication. Surg Endosc. 2002;16(1):48–53. PubMed.

    Article  CAS  PubMed  Google Scholar 

  44. Milkes D, Gerson LB, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD). Am J Gastroenterol. 2004;99(6):991–6. PubMed.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. SurgOne Foregut Institute, 401 W. Hampden Place, Suite 230, Englewood, CO, 80110, USA

    Reginald C. W. Bell M.D.

Authors
  1. Reginald C. W. Bell M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reginald C. W. Bell M.D. .

Editor information

Editors and Affiliations

  1. Cleveland Clinic, Section of Surgical Endoscopy, Cleveland, Ohio, USA

    Matthew Kroh

  2. The Oregon Clinic, Division of Gastrointestinal Surgery, Portland, Oregon, USA

    Kevin M. Reavis

Rights and permissions

Reprints and permissions

Copyright information

© 2016 SAGES

About this chapter

Cite this chapter

Bell, R.C.W. (2016). Endolumenal GERD Therapies. In: Kroh, M., Reavis, K. (eds) The SAGES Manual Operating Through the Endoscope. Springer, Cham. https://doi.org/10.1007/978-3-319-24145-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-24145-6_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-24143-2

  • Online ISBN: 978-3-319-24145-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation